Italy Respiratory Devices Market Size, Share, and COVID-19 Impact Analysis, By Application (Chronic Obstructive Pulmonary Disease (COPD), Sleep Apnea, Asthma, Infectious Diseases, and Others), By End-user (Hospitals and ASCs, Specialty Clinics, Home Care Settings, and Others), and Italy Respiratory Devices Market Insights, Industry Trend, Forecasts to 2033
Industry: HealthcareItaly Respiratory Devices Market Insights Forecasts to 2033
- The Italy Respiratory Devices Market Size is Expected to hold a significant share by 2023.
- The Market Size is Growing at a CAGR of 7.1% from 2023 to 2033
- The Italy Respiratory Devices Market Size is Expected to Hold a Significant Share by 2033
Get more details on this report -
The Italy Respiratory Devices Market Size is Anticipated to Hold a Significant Share by 2033, Growing at a CAGR of 7.1% from 2023 to 2033
Market Overview
Respiratory devices are pieces of equipment that aid in the breathing process by delivering the appropriate amount of oxygen to patients. These devices ensure that air is pumped under varying pressures into the lungs' airways while also protecting against hazardous substances in the air. The rising prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma, among others, is leading to an increase in inpatient and outpatient admissions, which is further increasing patient diagnosis and treatment rates. Also, as the diagnosis and treatment rate for respiratory disorders increases, so does the market demand for respiratory devices. Another factor contributing to the growing Italy respiratory devices market size is a strong focus on prominent market players developing and launching technologically advanced products to meet rising demand among healthcare providers and patients in the country. Additionally, the increased supply of these devices among healthcare companies and distributors aided in the growth of their annual revenue, which benefited the market.
Report Coverage
This research report categorizes for the Italy respiratory devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Italy respiratory devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Italy respiratory devices market.
Italy Respiratory Devices Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2023 |
Forecast Period: | 2023-2033 |
Forecast Period CAGR 2023-2033 : | 7.1% |
Historical Data for: | 2019-2022 |
No. of Pages: | 198 |
Tables, Charts & Figures: | 110 |
Segments covered: | By Application, By End-user |
Companies covered:: | Dragerwerk AG, Fisher & Paykel Healthcare Ltd, Fosun Pharmaceutical (Breas Medical AB), GE Healthcare, GlaxoSmithKline PLC, Invacare Corporation, Koninklijke Philips NV, Medtronic PLC, ICU Medical (Smiths Medical Inc.), and Others. |
Pitfalls & Challenges: | Covid-19 Empact, Challenges, Growth, Analysis. |
Get more details on this report -
Driving Factors
As the prevalence of respiratory conditions such as sleep apnea, chronic obstructive pulmonary disease (COPD), and asthma rises, so do diagnosis and treatment rates among patients. Also, the growing rate of diagnosis and treatment, as well as rising strategic initiatives by healthcare organizations to raise awareness, are driving up market demand for respiratory devices. Also, rising demand for advanced devices is driving respiratory equipment companies to introduce novel products to the market. Additionally, improved healthcare infrastructure in the country is expected to help these devices gain traction in the market.
Thus, technological advancements and increased adoption of these devices are expected to drive Italy respiratory devices market growth.
Restraining Factors
An insufficient number of respiratory professionals, as well as low patient adherence to treatment for respiratory disorders such as chronic obstructive pulmonary disease (COPD) and asthma, are expected to stymie patient adoption of these devices. This factor, combined with low patient adoption of respiratory devices, is expected to hinder market growth.
Market Segmentation
The Italy respiratory devices market share is classified into application and end-user
- The sleep apnea segment is expected to hold the largest market share through the forecast period.
The Italy respiratory devices market is segmented by application into chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases, and others. Among these, the sleep apnea segment is expected to hold the largest market share through the forecast period. The increasing prevalence of sleep apnea among patients has resulted in an increase in diagnosis and treatment rates. Also, as technology advances in breathing devices for sleep apnea, patient demand for these devices is expected to rise.
- The hospitals and ASCs segment is expected to dominate the Italy respiratory devices during the forecast period.
Based on the end-user, the Italy respiratory devices market is divided into hospitals and ASCs, specialty clinics, home care settings, and others. Among these, the hospitals and ASCs segment is expected to dominate the Italy respiratory devices market during the forecast period. The increasing number of patients admitted to hospitals and ASCs for treatment of sleep apnea, asthma, and other respiratory disorders. Also, the increasing number of hospital and ASC settings is expected to drive segment growth.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Italy respiratory devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Dragerwerk AG
- Fisher & Paykel Healthcare Ltd
- Fosun Pharmaceutical (Breas Medical AB)
- GE Healthcare
- GlaxoSmithKline PLC
- Invacare Corporation
- Koninklijke Philips NV
- Medtronic PLC
- ICU Medical (Smiths Medical Inc.)
- Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- In July 2022, The Bastide Group announced the acquisition of a majority stake in Oxystore, an Italian company near Milan. Oxystore focuses on consumer home diagnosis and online sales of oxygen therapy and sleep apnea products. It also offers support and follow-up services to patients undergoing home treatment.
Market Segment
This study forecasts revenue at Italy, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Italy respiratory devices market based on the below-mentioned segments:
Italy Respiratory Devices Market, By Application
- Chronic Obstructive Pulmonary Disease (COPD)
- Sleep Apnea
- Asthma
- Infectious Diseases
- Others
Italy Respiratory Devices Market, By End-User
- Hospitals and ASCs
- Specialty Clinics
- Home Care Settings
- Others
Need help to buy this report?